Reported Dec 6, 2017 · Terminated
Duloxetine Delayed-Release Capsules USP, 30 mg, 30-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals,…
Lupin Pharmaceuticals Inc.
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Lupin Pharmaceuticals Inc. · 111 S Calvert St Fl 21ST · Baltimore, MD · 21202-6174
Is this the product you have?
- Duloxetine Delayed-Release Capsules USP, 30 mg, 30-count bottles, Rx Only
- Manufactured forLupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States
- Manufactured by
Lupin Limited Goa 403 722 IndiaNDC 68180-295-06UPC 368180295068
- Lot codes and dates
Lot #: G602051Exp. 12/2017
- Amount recalled
- 111,648 units
Where it was sold
- Nationwide
Why it was recalled
Failed Dissolution Specification
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Lupin Pharmaceuticals Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.